Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
- PMID: 33052972
- PMCID: PMC7556447
- DOI: 10.1371/journal.pone.0240965
Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Expression of concern for
-
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.PLoS One. 2020 Sep 25;15(9):e0239799. doi: 10.1371/journal.pone.0239799. eCollection 2020. PLoS One. 2020. Retraction in: PLoS One. 2024 Jun 6;19(6):e0305303. doi: 10.1371/journal.pone.0305303 PMID: 32976513 Free PMC article. Retracted.
Similar articles
-
Retraction: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.PLoS One. 2024 Jun 6;19(6):e0305303. doi: 10.1371/journal.pone.0305303. eCollection 2024. PLoS One. 2024. PMID: 38843134 Free PMC article. No abstract available.
-
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.Am J Nephrol. 2019;49(4):284-293. doi: 10.1159/000499187. Epub 2019 Mar 15. Am J Nephrol. 2019. PMID: 30878999 Clinical Trial.
-
Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill.Crit Care Med. 2014 Jan;42(1):97-107. doi: 10.1097/CCM.0b013e31829eb7af. Crit Care Med. 2014. PMID: 23982028
-
Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations and Physical Performance in Athletes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Sports Med. 2017 Nov;47(11):2323-2339. doi: 10.1007/s40279-017-0749-4. Sports Med. 2017. PMID: 28577257 Review.
-
Vitamin D deficiency in children: a challenging diagnosis!Pediatr Res. 2019 Apr;85(5):596-601. doi: 10.1038/s41390-019-0289-8. Epub 2019 Jan 17. Pediatr Res. 2019. PMID: 30653195 Review.
Cited by
-
Disputes over the production and dissemination of misinformation in the time of COVID-19.Respir Med. 2021 Jun;182:106380. doi: 10.1016/j.rmed.2021.106380. Epub 2021 Mar 29. Respir Med. 2021. PMID: 33930690 Free PMC article.
-
The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis.Metabolism. 2021 Jun;119:154753. doi: 10.1016/j.metabol.2021.154753. Epub 2021 Mar 24. Metabolism. 2021. PMID: 33774074 Free PMC article.
-
Retraction: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.PLoS One. 2024 Jun 6;19(6):e0305303. doi: 10.1371/journal.pone.0305303. eCollection 2024. PLoS One. 2024. PMID: 38843134 Free PMC article. No abstract available.
-
Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update.Front Cardiovasc Med. 2020 Dec 23;7:616527. doi: 10.3389/fcvm.2020.616527. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33426009 Free PMC article. Review.
-
Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approach.World J Virol. 2021 May 25;10(3):111-129. doi: 10.5501/wjv.v10.i3.111. World J Virol. 2021. PMID: 34079693 Free PMC article.
References
-
- Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, et al. (2020) Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS ONE 15(9): e0239799 10.1371/journal.pone.0239799 - DOI - PMC - PubMed
-
- Talebpour M, Hadadi A, Oraii A, Ashraf H. Rationale and Design of a Registry in a Referral and Educational Medical Center in Tehran, Iran: Sina Hospital Covid-19 Registry (SHCo-19R). Adv J Emerg Med. 4(2s):e53.
Publication types
LinkOut - more resources
Full Text Sources